Copyright Reports & Markets. All rights reserved.

Global α-adrenoreceptor Antagonists Market Professional Survey Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Executive Summary

      1 Industry Overview of α-adrenoreceptor Antagonists

      • 1.1 Definition of α-adrenoreceptor Antagonists
      • 1.2 α-adrenoreceptor Antagonists Segment by Type
        • 1.2.1 Global α-adrenoreceptor Antagonists Production Growth Rate Comparison by Types (2014-2025)
        • 1.2.2 Non-selective Antagonists
        • 1.2.3 Selective Antagonists
      • 1.3 α-adrenoreceptor Antagonists Segment by Applications
        • 1.3.1 Global α-adrenoreceptor Antagonists Consumption Comparison by Applications (2014-2025)
        • 1.3.2 Hypertension
        • 1.3.3 Raynaud's Disease
        • 1.3.4 Erectile Dysfunction
      • 1.4 Global α-adrenoreceptor Antagonists Overall Market
        • 1.4.1 Global α-adrenoreceptor Antagonists Revenue (2014-2025)
        • 1.4.2 Global α-adrenoreceptor Antagonists Production (2014-2025)
        • 1.4.3 North America α-adrenoreceptor Antagonists Status and Prospect (2014-2025)
        • 1.4.4 Europe α-adrenoreceptor Antagonists Status and Prospect (2014-2025)
        • 1.4.5 China α-adrenoreceptor Antagonists Status and Prospect (2014-2025)
        • 1.4.6 Japan α-adrenoreceptor Antagonists Status and Prospect (2014-2025)
        • 1.4.7 Southeast Asia α-adrenoreceptor Antagonists Status and Prospect (2014-2025)
        • 1.4.8 India α-adrenoreceptor Antagonists Status and Prospect (2014-2025)

      2 Manufacturing Cost Structure Analysis

      • 2.1 Raw Material and Suppliers
      • 2.2 Manufacturing Cost Structure Analysis of α-adrenoreceptor Antagonists
      • 2.3 Manufacturing Process Analysis of α-adrenoreceptor Antagonists
      • 2.4 Industry Chain Structure of α-adrenoreceptor Antagonists

      3 Development and Manufacturing Plants Analysis of α-adrenoreceptor Antagonists

      • 3.1 Capacity and Commercial Production Date
      • 3.2 Global α-adrenoreceptor Antagonists Manufacturing Plants Distribution
      • 3.3 Major Manufacturers Technology Source and Market Position of α-adrenoreceptor Antagonists
      • 3.4 Recent Development and Expansion Plans

      4 Key Figures of Major Manufacturers

      • 4.1 α-adrenoreceptor Antagonists Production and Capacity Analysis
      • 4.2 α-adrenoreceptor Antagonists Revenue Analysis
      • 4.3 α-adrenoreceptor Antagonists Price Analysis
      • 4.4 Market Concentration Degree

      5 α-adrenoreceptor Antagonists Regional Market Analysis

      • 5.1 α-adrenoreceptor Antagonists Production by Regions
        • 5.1.1 Global α-adrenoreceptor Antagonists Production by Regions
        • 5.1.2 Global α-adrenoreceptor Antagonists Revenue by Regions
      • 5.2 α-adrenoreceptor Antagonists Consumption by Regions
      • 5.3 North America α-adrenoreceptor Antagonists Market Analysis
        • 5.3.1 North America α-adrenoreceptor Antagonists Production
        • 5.3.2 North America α-adrenoreceptor Antagonists Revenue
        • 5.3.3 Key Manufacturers in North America
        • 5.3.4 North America α-adrenoreceptor Antagonists Import and Export
      • 5.4 Europe α-adrenoreceptor Antagonists Market Analysis
        • 5.4.1 Europe α-adrenoreceptor Antagonists Production
        • 5.4.2 Europe α-adrenoreceptor Antagonists Revenue
        • 5.4.3 Key Manufacturers in Europe
        • 5.4.4 Europe α-adrenoreceptor Antagonists Import and Export
      • 5.5 China α-adrenoreceptor Antagonists Market Analysis
        • 5.5.1 China α-adrenoreceptor Antagonists Production
        • 5.5.2 China α-adrenoreceptor Antagonists Revenue
        • 5.5.3 Key Manufacturers in China
        • 5.5.4 China α-adrenoreceptor Antagonists Import and Export
      • 5.6 Japan α-adrenoreceptor Antagonists Market Analysis
        • 5.6.1 Japan α-adrenoreceptor Antagonists Production
        • 5.6.2 Japan α-adrenoreceptor Antagonists Revenue
        • 5.6.3 Key Manufacturers in Japan
        • 5.6.4 Japan α-adrenoreceptor Antagonists Import and Export
      • 5.7 Southeast Asia α-adrenoreceptor Antagonists Market Analysis
        • 5.7.1 Southeast Asia α-adrenoreceptor Antagonists Production
        • 5.7.2 Southeast Asia α-adrenoreceptor Antagonists Revenue
        • 5.7.3 Key Manufacturers in Southeast Asia
        • 5.7.4 Southeast Asia α-adrenoreceptor Antagonists Import and Export
      • 5.8 India α-adrenoreceptor Antagonists Market Analysis
        • 5.8.1 India α-adrenoreceptor Antagonists Production
        • 5.8.2 India α-adrenoreceptor Antagonists Revenue
        • 5.8.3 Key Manufacturers in India
        • 5.8.4 India α-adrenoreceptor Antagonists Import and Export

      6 α-adrenoreceptor Antagonists Segment Market Analysis (by Type)

      • 6.1 Global α-adrenoreceptor Antagonists Production by Type
      • 6.2 Global α-adrenoreceptor Antagonists Revenue by Type
      • 6.3 α-adrenoreceptor Antagonists Price by Type

      7 α-adrenoreceptor Antagonists Segment Market Analysis (by Application)

      • 7.1 Global α-adrenoreceptor Antagonists Consumption by Application
      • 7.2 Global α-adrenoreceptor Antagonists Consumption Market Share by Application (2014-2019)

      8 α-adrenoreceptor Antagonists Major Manufacturers Analysis

      • 8.1 Pfizer
        • 8.1.1 Pfizer α-adrenoreceptor Antagonists Production Sites and Area Served
        • 8.1.2 Pfizer Product Introduction, Application and Specification
        • 8.1.3 Pfizer α-adrenoreceptor Antagonists Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.1.4 Main Business and Markets Served
      • 8.2 Novartis
        • 8.2.1 Novartis α-adrenoreceptor Antagonists Production Sites and Area Served
        • 8.2.2 Novartis Product Introduction, Application and Specification
        • 8.2.3 Novartis α-adrenoreceptor Antagonists Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.2.4 Main Business and Markets Served
      • 8.3 Merck
        • 8.3.1 Merck α-adrenoreceptor Antagonists Production Sites and Area Served
        • 8.3.2 Merck Product Introduction, Application and Specification
        • 8.3.3 Merck α-adrenoreceptor Antagonists Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.3.4 Main Business and Markets Served
      • 8.4 Astra Zeneca
        • 8.4.1 Astra Zeneca α-adrenoreceptor Antagonists Production Sites and Area Served
        • 8.4.2 Astra Zeneca Product Introduction, Application and Specification
        • 8.4.3 Astra Zeneca α-adrenoreceptor Antagonists Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.4.4 Main Business and Markets Served
      • 8.5 Jhonson and Johnson
        • 8.5.1 Jhonson and Johnson α-adrenoreceptor Antagonists Production Sites and Area Served
        • 8.5.2 Jhonson and Johnson Product Introduction, Application and Specification
        • 8.5.3 Jhonson and Johnson α-adrenoreceptor Antagonists Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.5.4 Main Business and Markets Served
      • 8.6 Eli Lilly
        • 8.6.1 Eli Lilly α-adrenoreceptor Antagonists Production Sites and Area Served
        • 8.6.2 Eli Lilly Product Introduction, Application and Specification
        • 8.6.3 Eli Lilly α-adrenoreceptor Antagonists Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.6.4 Main Business and Markets Served
      • 8.7 Sanofi
        • 8.7.1 Sanofi α-adrenoreceptor Antagonists Production Sites and Area Served
        • 8.7.2 Sanofi Product Introduction, Application and Specification
        • 8.7.3 Sanofi α-adrenoreceptor Antagonists Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.7.4 Main Business and Markets Served
      • 8.8 Bristol-Myers Squibb
        • 8.8.1 Bristol-Myers Squibb α-adrenoreceptor Antagonists Production Sites and Area Served
        • 8.8.2 Bristol-Myers Squibb Product Introduction, Application and Specification
        • 8.8.3 Bristol-Myers Squibb α-adrenoreceptor Antagonists Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.8.4 Main Business and Markets Served
      • 8.9 Bayer
        • 8.9.1 Bayer α-adrenoreceptor Antagonists Production Sites and Area Served
        • 8.9.2 Bayer Product Introduction, Application and Specification
        • 8.9.3 Bayer α-adrenoreceptor Antagonists Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.9.4 Main Business and Markets Served
      • 8.10 GSK
        • 8.10.1 GSK α-adrenoreceptor Antagonists Production Sites and Area Served
        • 8.10.2 GSK Product Introduction, Application and Specification
        • 8.10.3 GSK α-adrenoreceptor Antagonists Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.10.4 Main Business and Markets Served
      • 8.11 Teva Pharmaceutical

      9 Development Trend of Analysis of α-adrenoreceptor Antagonists Market

      • 9.1 Global α-adrenoreceptor Antagonists Market Trend Analysis
        • 9.1.1 Global α-adrenoreceptor Antagonists Market Size (Volume and Value) Forecast 2019-2025
      • 9.2 α-adrenoreceptor Antagonists Regional Market Trend
        • 9.2.1 North America α-adrenoreceptor Antagonists Forecast 2019-2025
        • 9.2.2 Europe α-adrenoreceptor Antagonists Forecast 2019-2025
        • 9.2.3 China α-adrenoreceptor Antagonists Forecast 2019-2025
        • 9.2.4 Japan α-adrenoreceptor Antagonists Forecast 2019-2025
        • 9.2.5 Southeast Asia α-adrenoreceptor Antagonists Forecast 2019-2025
        • 9.2.6 India α-adrenoreceptor Antagonists Forecast 2019-2025
      • 9.3 α-adrenoreceptor Antagonists Market Trend (Product Type)
      • 9.4 α-adrenoreceptor Antagonists Market Trend (Application)
      • 10.1 Marketing Channel
        • 10.1.1 Direct Marketing
        • 10.1.2 Indirect Marketing
      • 10.3 α-adrenoreceptor Antagonists Customers

      11 Market Dynamics

      • 11.1 Market Trends
      • 11.2 Opportunities
      • 11.3 Market Drivers
      • 11.4 Challenges
      • 11.5 Influence Factors

      12 Conclusion

        13 Appendix

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        α-adrenoreceptor antagonists are a class of pharmacological agents that act as antagonists on α-adrenergic receptors (α-adrenoceptors).

        The global α-adrenoreceptor Antagonists market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
        This report focuses on α-adrenoreceptor Antagonists volume and value at global level, regional level and company level. From a global perspective, this report represents overall α-adrenoreceptor Antagonists market size by analyzing historical data and future prospect.
        Regionally, this report categorizes the production, apparent consumption, export and import of α-adrenoreceptor Antagonists in North America, Europe, China, Japan, Southeast Asia and India.
        For each manufacturer covered, this report analyzes their α-adrenoreceptor Antagonists manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

        The following manufacturers are covered:
        Pfizer
        Novartis
        Merck
        Astra Zeneca
        Jhonson and Johnson
        Eli Lilly
        Sanofi
        Bristol-Myers Squibb
        Bayer
        GSK
        Teva Pharmaceutical

        Segment by Regions
        North America
        Europe
        China
        Japan
        Southeast Asia
        India

        Segment by Type
        Non-selective Antagonists
        Selective Antagonists

        Segment by Application
        Hypertension
        Raynaud's Disease
        Erectile Dysfunction

        Buy now